EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs

Luana Boumendil iD, Sylvie Chevret, Vincent Lévy, Lucie Biard

Statistics in Medicine · 2024

DOI: 10.1002/sim.10130 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Luana Boumendil und 3 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1153, Team ECSTRRA, Hôpital Saint Louis, Paris, France. Hauptthemen laut MEDLINE: Bayes Theorem, Randomized Controlled Trials as Topic, Computer Simulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adaptive randomized clinical trials are of major interest when dealing with a time‐to‐event outcome in a prolonged observation window. No consensus exists either to define stopping boundaries or to combine values or test statistics in the terminal analysis in the case of a frequentist design and sample size adaptation. In a one‐sided setting, we compared three frequentist approaches using stopping boundaries relying on ‐spending functions and a Bayesian monitoring setting with boundaries based on the posterior distribution of the log‐hazard ratio. All designs comprised a single interim analysis with an efficacy stopping rule and the possibility of sample size adaptation at this interim step. Three frequentist approaches were defined based on the terminal analysis: combination of stagewise statistics (Wassmer) or of values (Desseaux), or on patientwise splitting (Jörgens), and we compared the results with those of the Bayesian monitoring approach (Freedman). These different approaches were evaluated in a simulation study and then illustrated on a real dataset from a randomized clinical trial conducted in elderly patients with chronic lymphocytic leukemia. All approaches controlled for the type I error rate, except for the Bayesian monitoring approach, and yielded satisfactory power. It appears that the frequentist approaches are the best in underpowered trials. The power of all the approaches was affected by the violation of the proportional hazards (PH) assumption. For adaptive designs with a survival endpoint and a one‐sided alternative hypothesis, the Wassmer and Jörgens approaches after sample size adaptation should be preferred, unless violation of PH is suspected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bayes TheoremRandomized Controlled Trials as TopicComputer SimulationHumansSample SizeResearch DesignEndpoint DeterminationLeukemia, Lymphocytic, Chronic, B-CellModels, Statistical

Stichwörter der Autor:innen

Bayesian boundariesadaptive designcombination testinterim analysissurvival trial

Autor:innen und Institutionen

  • INSERM U1153, Team ECSTRRA, Hôpital Saint Louis, Paris, France.
  • Université Paris Cité, Paris, France.
  • AP-HP Hôpital Saint Louis, Service de Biostatistique et Information Médicale, Paris, France.
  • Université Paris 13, Villetaneuse, France.
  • AP-HP Hôpital Avicenne, Unité de Recherche Clinique Bobigny, Bobigny, France.

ORCID-Profile: Luana Boumendil

Zitieren

APA

Boumendil, L., Chevret, S., Lévy, V., & Biard, L. (2024). Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs. Statistics in Medicine. https://doi.org/10.1002/sim.10130

Vancouver

Boumendil L, Chevret S, Lévy V, Biard L. Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs. Statistics in Medicine. 2024. doi:10.1002/sim.10130

BibTeX
@article{Boumendil2024,
  author = {Boumendil, Luana and Chevret, Sylvie and Lévy, Vincent and Biard, Lucie},
  title = {Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs},
  journal = {Statistics in Medicine},
  year = {2024},
  doi = {10.1002/sim.10130}
}
Kostenlos starten →